{
  "abstract": "The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in patients who are in the early stages of the disease.",
  "authors": [
    {
      "affiliations": [
        "The BMJ"
      ],
      "name": "Kate Bowie"
    }
  ],
  "title": "Type 1 diabetes: UK approves first drug for delaying onset",
  "uid": "5a685d7d-6ff8-5ba1-9382-33400584519c"
}